Watch CNBC's full interview with Boston Scientific CEO Mike Mahoney

CEO Mike Mahoney shared our plans for growth with CNBC's Meg Tirrell on 'The Exchange'. Hear why in the midst of changing economic considerations we continue to focus on finding the innovation sweet spot in interventional medicine that will provide the most value for patients. See the full clip here.